Cargando…
Distinct cell-specific control of autoimmunity and infection by FcγRIIb
FcγRIIb is an inhibitory Fc receptor expressed on B cells and myeloid cells. It is important in controlling responses to infection, and reduced expression or function predisposes to autoimmunity. To determine if increased expression of FcγRIIb can modulate these processes, we created transgenic mice...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292226/ https://www.ncbi.nlm.nih.gov/pubmed/18362174 http://dx.doi.org/10.1084/jem.20072565 |
_version_ | 1782152488640577536 |
---|---|
author | Brownlie, Rebecca J. Lawlor, Kate E. Niederer, Heather A. Cutler, Antony J. Xiang, Zou Clatworthy, Menna R. Floto, R. Andres Greaves, David R. Lyons, Paul A. Smith, Kenneth G.C. |
author_facet | Brownlie, Rebecca J. Lawlor, Kate E. Niederer, Heather A. Cutler, Antony J. Xiang, Zou Clatworthy, Menna R. Floto, R. Andres Greaves, David R. Lyons, Paul A. Smith, Kenneth G.C. |
author_sort | Brownlie, Rebecca J. |
collection | PubMed |
description | FcγRIIb is an inhibitory Fc receptor expressed on B cells and myeloid cells. It is important in controlling responses to infection, and reduced expression or function predisposes to autoimmunity. To determine if increased expression of FcγRIIb can modulate these processes, we created transgenic mice overexpressing FcγRIIb on B cells or macrophages. Overexpression of FcγRIIb on B cells reduced the immunoglobulin G component of T-dependent immune responses, led to early resolution of collagen-induced arthritis (CIA), and reduced spontaneous systemic lupus erythematosus (SLE). In contrast, overexpression on macrophages had no effect on immune responses, CIA, or SLE but increased mortality after Streptococcus pneumoniae infection. These results help define the role of FcγRIIb in immune responses, demonstrate the contrasting roles played by FcγRIIb on B cells and macrophages in the control of infection and autoimmunity, and emphasize the therapeutic potential for modulation of FcγRIIb expression on B cells in inflammatory and autoimmune disease. |
format | Text |
id | pubmed-2292226 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22922262008-10-14 Distinct cell-specific control of autoimmunity and infection by FcγRIIb Brownlie, Rebecca J. Lawlor, Kate E. Niederer, Heather A. Cutler, Antony J. Xiang, Zou Clatworthy, Menna R. Floto, R. Andres Greaves, David R. Lyons, Paul A. Smith, Kenneth G.C. J Exp Med Articles FcγRIIb is an inhibitory Fc receptor expressed on B cells and myeloid cells. It is important in controlling responses to infection, and reduced expression or function predisposes to autoimmunity. To determine if increased expression of FcγRIIb can modulate these processes, we created transgenic mice overexpressing FcγRIIb on B cells or macrophages. Overexpression of FcγRIIb on B cells reduced the immunoglobulin G component of T-dependent immune responses, led to early resolution of collagen-induced arthritis (CIA), and reduced spontaneous systemic lupus erythematosus (SLE). In contrast, overexpression on macrophages had no effect on immune responses, CIA, or SLE but increased mortality after Streptococcus pneumoniae infection. These results help define the role of FcγRIIb in immune responses, demonstrate the contrasting roles played by FcγRIIb on B cells and macrophages in the control of infection and autoimmunity, and emphasize the therapeutic potential for modulation of FcγRIIb expression on B cells in inflammatory and autoimmune disease. The Rockefeller University Press 2008-04-14 /pmc/articles/PMC2292226/ /pubmed/18362174 http://dx.doi.org/10.1084/jem.20072565 Text en Copyright © 2008, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Brownlie, Rebecca J. Lawlor, Kate E. Niederer, Heather A. Cutler, Antony J. Xiang, Zou Clatworthy, Menna R. Floto, R. Andres Greaves, David R. Lyons, Paul A. Smith, Kenneth G.C. Distinct cell-specific control of autoimmunity and infection by FcγRIIb |
title | Distinct cell-specific control of autoimmunity and infection by FcγRIIb |
title_full | Distinct cell-specific control of autoimmunity and infection by FcγRIIb |
title_fullStr | Distinct cell-specific control of autoimmunity and infection by FcγRIIb |
title_full_unstemmed | Distinct cell-specific control of autoimmunity and infection by FcγRIIb |
title_short | Distinct cell-specific control of autoimmunity and infection by FcγRIIb |
title_sort | distinct cell-specific control of autoimmunity and infection by fcγriib |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292226/ https://www.ncbi.nlm.nih.gov/pubmed/18362174 http://dx.doi.org/10.1084/jem.20072565 |
work_keys_str_mv | AT brownlierebeccaj distinctcellspecificcontrolofautoimmunityandinfectionbyfcgriib AT lawlorkatee distinctcellspecificcontrolofautoimmunityandinfectionbyfcgriib AT niedererheathera distinctcellspecificcontrolofautoimmunityandinfectionbyfcgriib AT cutlerantonyj distinctcellspecificcontrolofautoimmunityandinfectionbyfcgriib AT xiangzou distinctcellspecificcontrolofautoimmunityandinfectionbyfcgriib AT clatworthymennar distinctcellspecificcontrolofautoimmunityandinfectionbyfcgriib AT flotorandres distinctcellspecificcontrolofautoimmunityandinfectionbyfcgriib AT greavesdavidr distinctcellspecificcontrolofautoimmunityandinfectionbyfcgriib AT lyonspaula distinctcellspecificcontrolofautoimmunityandinfectionbyfcgriib AT smithkennethgc distinctcellspecificcontrolofautoimmunityandinfectionbyfcgriib |